{"formatVersion":"1.1","id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis","path":"/library/mental-health-behavioral-addiction-dual-diagnosis","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis","title":"Dual Diagnosis in Mental Health and Addiction","family":"Library detail","description":"Discover how dual diagnoses combine mental health and addiction disorders, sharing risk factors and complicating treatment.","language":"en-US","access":{"audience":"custom-shared-preview","indexable":true},"provenance":{"sourceUrl":"https://www.mentalhealth.com/library/mental-health-behavioral-addiction-dual-diagnosis","wordpressId":"5233","contentCompleteness":"complete","dateScope":"original-source"},"authors":[{"@type":"Person","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/simone-hoermann#person","name":"Simone Hoermann, Ph.D.","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/simone-hoermann"}],"reviewer":{"@type":"Person","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/carlos-protzel#person","name":"Carlos Protzel, Psy.D.","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/carlos-protzel"},"dates":{"datePublished":"2025-05-27T09:14:27Z","dateModified":"2026-05-12T11:52:34Z","lastReviewed":"2025-05-27"},"content":{"html":"

Dual Diagnosis in Mental Health and Addiction

Written by \"\"Simone Hoermann, Ph.D.Medically reviewed by \"\"Carlos Protzel, Psy.D.

Published on · Updated on

A dual diagnosis occurs when an individual experiences both a mental health condition and a substance use disorder simultaneously. This co-occurrence is more common than many realize, and it presents unique challenges in diagnosis and treatment. Mental health issues such as depression, anxiety, or bipolar disorder can contribute to substance use. At the same time, addiction can worsen or trigger psychiatric symptoms, significantly impacting a person’s physical, emotional, and social well-being. Effective treatment requires an integrated, holistic approach that addresses both conditions at the same time.

\"A

Key takeaways

  • Dual diagnosis involves a mental health condition occurring alongside a substance use disorder.
  • Overlapping symptoms and reciprocal worsening can make recognition and treatment more complex.
  • Integrated care combines appropriate therapies, medication, and support to address both conditions together.

What Is a Dual Diagnosis?

Dual diagnosis, also known as co-occurring disorders, refers to the presence of both a mental health condition and a substance use disorder. These conditions often develop together and can significantly impact one another, intensifying symptoms and complicating treatment. For example, an individual struggling with depression may become dependent on benzodiazepines, or someone with post-traumatic stress disorder (PTSD) might develop an opioid use disorder. These conditions often share overlapping biological, psychological, and social risk factors, which may explain why they frequently appear together [1].

Understanding these shared influences is essential for developing effective, integrated treatment approaches that address both issues simultaneously [2].

One of the most common pathways to co-occurring disorders is self-medication. Individuals experiencing mental health symptoms may turn to substances like alcohol or drugs to numb emotional pain or manage anxiety. However, self-medicating provides only temporary relief and can quickly lead to addiction, creating a destructive cycle where mental illness and substance use continuously reinforce each other [3].

Common Co-Occurring Mental Health Disorders and Addictions

Many substance use disorders co-occur with mental health conditions. However, some pairings are seen more frequently than others. These include: 

Depression and Alcohol

​​When exploring the intersection of mental health and addiction, one of the most common and well-documented co-occurring disorders is depression paired with alcohol use disorder. On their own, these are two of the most prevalent psychiatric conditions—but when they occur together, they can significantly worsen one another. Research shows that individuals with alcohol use disorder are more than twice as likely to experience depression [4].

Both conditions can run in families, pointing to a genetic predisposition that increases vulnerability to developing one or both. However, genetics is only part of the story. A range of social and environmental factors, such as adverse childhood experiences, trauma, chronic stress, or poor living conditions, can also play a significant role in increasing the risk of both alcohol misuse and depression [5].

Understanding this overlap is essential for delivering effective, integrated treatment that addresses dual diagnosis's emotional and behavioral components.

Anxiety and Prescription Drugs

People with anxiety are at an increased risk of developing a prescription drug addiction. Prescription drug abuse can either involve non-medical use (individuals with a prescription but using the drug outside of the intended use or frequency) or use without a prescription. Although both forms of prescription misuse occur at higher rates in individuals with anxiety, non-medical use is more than twice as likely to happen when compared to use without a prescription [6].

It is generally believed that self-medicating is a significant motivator for this behavior. People with uncontrolled anxiety often turn to increased amounts of more potent medications in an attempt to dull anxious feelings [6]. 

Attention-deficit/hyperactivity disorder (ADHD) and Stimulant Use

Many people are concerned about the possibility of addiction amongst individuals prescribed stimulants to treat attention-deficit hyperactivity disorder (ADHD). However, extensive research has conclusively disproven this assertion. Studies have shown that prescribing stimulants appropriately to people with ADHD reduces the risk of developing a substance use disorder [7].

There may be a slightly increased risk of non-prescription stimulant use in people with ADHD symptoms who have not received a formal diagnosis. However, the evidence is unclear if this causes an increased risk of addiction. This underscores the importance of recognizing dual diagnoses early, as overlapping symptoms can mask underlying conditions and complicate treatment outcomes [7]. 

Recognizing the Signs of Addiction and Mental Health Struggles

Addiction and mental health conditions can manifest in many different ways. It's not always obvious when someone is struggling; in many cases, the warning signs can be subtle or easily overlooked.

Some common signs of a potential substance use disorder include [8]:

    \n
  • Using substances in larger amounts or for more extended periods than intended.
    • \n
  • Wanting to cut down or stop, but feeling unable to.
    • \n
  • Experiencing negative effects on daily responsibilities, education, work, or relationships.
    • \n
  • Continuing to use substances despite knowing they cause harm.
    • \n
  • Developing a tolerance and experiencing withdrawal symptoms when not using.
    • \n

Mental health symptoms can vary widely depending on the condition, but when combined with substance use, these symptoms often become more severe. Co-occurring addiction may worsen emotional distress, impair day-to-day functioning, and further isolate individuals from supportive relationships, making it even harder to seek and receive help.

Risk Factors for Addiction and Mental Health Conditions

Healthcare professionals classify addiction as a mental health disorder. This is because although many substances have a physical dependence aspect, addiction is primarily a behavioral and psychological condition. This becomes clear when we look at some of the shared dual diagnosis risk factors for both addiction and other mental health conditions:

    \n
  • Genetics: A person’s genes can increase the risk of developing an addiction or a mental health disorder. Specific ‘risk genes’, inherited response to dopamine (the brain’s reward chemical), and genetic personality factors (such as increased neuroticism and impulsivity) affect the risk of developing these co-occurring conditions [9]. 
    • \n
  • Environmental: Environmental factors, such as exposure to substance misuse and parental mental health difficulties, can increase the risk of developing both conditions. Other childhood factors, such as experiencing trauma, abuse, or neglect, can also impact an individual’s experience of these diseases [10]. 
    • \n
  • Social: Wider socio-economic influences can also have a significant impact on a person’s risk of developing addiction or another mental health disorder. Lack of education, resources, and healthcare access all contribute to this risk [10]. 
    • \n

The Challenges of a Dual Diagnosis

The overlap in symptoms between addiction and other mental health problems can make an accurate diagnosis tricky. Specialists can use assessment tools to prevent misdiagnosis and arrange the correct treatment for both conditions. Both conditions must be treated together, focusing on each individual’s needs [11].

Integrated care is one of the best ways to treat co-occurring conditions effectively. This approach involves collaboration among various healthcare professionals to establish an assessment and treatment plan that addresses the patient’s physical, psychological, and social needs. Studies have shown that integrated care improves symptoms, enhances access to services, improves quality of care, and reduces healthcare costs [12].

Without simultaneous treatment, patients risk entering a cycle where untreated mental health symptoms perpetuate substance use, and vice versa, making recovery nearly impossible without addressing both conditions holistically.

Therapeutic Approaches for Co-Occurring Mental Health and Addiction Disorders

Effective treatment for co-occurring mental health and substance use disorders often requires a comprehensive, integrated approach. Rehabilitation programs that address both conditions simultaneously are considered the cornerstone of intensive care. Several types of therapy have proven effective in treating these comorbid conditions [13]:

    \n
  • Self-Help Groups: Programs such as 12-step fellowships (e.g., Alcoholics Anonymous or Narcotics Anonymous) are widely used in addiction recovery. While these groups may not directly address mental health conditions, they foster community, accountability, and shared experience, elements that can reduce isolation and support emotional healing in those with co-occurring psychiatric symptoms.
    • \n
  • Brief Interventions: For individuals with mild or early-stage addiction, brief interventions conducted by primary care physicians or specialists can be effective. These interventions typically involve screening, brief counseling, and follow-up, and may address underlying mental health issues contributing to substance use.
    • \n
  • Cognitive Behavioral Therapy (CBT): CBT is one of the most widely used evidence-based therapies for co-occurring disorders. It helps individuals identify harmful thought patterns, understand behavioral triggers, and develop healthy coping strategies. CBT is especially valuable in treating comorbidity because it targets the link between substance use and mental health symptoms, improving the likelihood of sustained recovery.
    • \n
  • Psychodynamic Psychotherapy: This approach focuses on uncovering the root causes of emotional distress, often tracing back to early life experiences and unresolved trauma. By exploring the underlying psychological drivers of both addiction and mental health conditions, individuals gain deeper insight into their behaviors, which can support long-term healing.
    • \n

Each of these therapies may be used independently or in combination as part of a personalized treatment plan, depending on the individual’s needs and the severity of their conditions.

Medication for Mental Health Conditions and Addiction

Medication is an essential part of the treatment of many addictions and mental health disorders. Healthcare professionals take great care to ensure that any prescribed medications do not worsen the symptoms of other co-occurring disorders. Several medications may have a beneficial effect in treating more than one condition. The use of medication in treating mental health conditions is most effective when done alongside therapy and other social interventions.

Some common groups of medications that doctors prescribe to treat mental health disorders include [13][14]: 

    \n
  • Antidepressants: Commonly used to treat depression, these medications can help in the treatment of other conditions (such as anxiety or chronic pain). Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed type of antidepressant. Addiction commonly involves an element of low mood that can be treated with antidepressants.
    • \n
  • Anti-Anxiety Medications: These medications treat anxiety, panic attacks, and extreme phobias. SSRIs and other antidepressants can have an anti-anxiety action. Benzodiazepines are another type of anti-anxiety medication, but these are used with caution in people with a substance use disorder as they can be addictive. Anti-anxiety medications may be used during substance detox or abstinence to counteract the increased anxiety that this process can commonly result in.
    • \n
  • Mood Stabilizers: These medications are used to treat bipolar disorder, as well as other disorders involving impulse control. Lithium, as well as some anti-epilepsy medications, are commonly used as mood stabilizers. These drugs can have significant side effects, so people who take them must undergo regular monitoring. Treating a co-occurring bipolar or impulse control disorder can reduce the chance of relapse in individuals with a substance use disorder.
    • \n
  • Medications for Addiction: There are many different medications used to treat addiction, depending on the specific substance involved. Disulfiram and acamprosate are prescribed for alcohol use disorder. Methadone and buprenorphine are commonly used to treat opioid addiction. Other medications, such as naltrexone, can be used as part of the treatment for a variety of substance addictions. These medications all have different effects that can potentially improve or worsen symptoms of a co-occurring disorder.
    • \n

Understanding how medications are used to treat these conditions can be challenging. For more information and advice on what medications may suit you, seek help from your healthcare provider.

Managing Co-Occurring Disorders

Co-occurring disorders represent a complex and often intertwined relationship between mental health conditions and substance use disorders. These conditions frequently share underlying risk factors, such as trauma, genetic predisposition, and chronic stress, which can make early recognition and targeted intervention especially important. When left untreated, one disorder can worsen the symptoms of the other, creating a cycle that is difficult to break.

Integrated, comprehensive care is essential for successful treatment. Approaching both mental health and addiction simultaneously, rather than in isolation, helps individuals build insight, develop healthier coping mechanisms, and reduce the risk of relapse. Treatment often includes therapy, medication, peer support, and lifestyle changes tailored to individual needs.

With early intervention, a strong support system, and access to appropriate clinical care, recovery is possible and realistic. Individuals can regain control, improve well-being, and achieve a sustainable, healthier future.

References

    \n
  1. National Institute on Drug Abuse. (2024, April 19). Co-Occurring Disorders and Health Conditions | National Institute on Drug Abuse. National Institute on Drug Abuse. National Institute on Drug Abuse. Accessed May 29 2025.
    2. \n
  2. Hardie, M. (2021). Three Aspects of Health and Healing: The Biopsychosocial Model in Medicine. Washington School of Medicine in St. Louis Department of Surgery. surgery.wustl.edu. Accessed May 29 2025.
    3. \n
  3. Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. PubMed. Accessed May 29 2025.
    4. \n
  4. McHugh, R. K., & Weiss, R. D. (2019). Alcohol Use Disorder and Depressive Disorders. Alcohol Research: Current Reviews, 40(1). PubMed Central. Accessed May 29 2025.
    5. \n
  5. Substance use and co-occurring mental disorders. (2024, March). National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.
    6. \n
  6. Fenton, M. C., Keyes, K. M., Martins, S. S., & Hasin, D. S. (2010). The Role of a Prescription in Anxiety Medication Use, Abuse, and Dependence. American Journal of Psychiatry, 167(10), 1247–1253. PubMed Central. Accessed May 29 2025.
    7. \n
  7. Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2013). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885. PubMed. Accessed May 29 2025.
    8. \n
  8. McLellan, A. T. (2017). Substance Misuse and Substance use Disorders: Why do they Matter in Healthcare? Transactions of the American Clinical and Climatological Association, 128, 112. PubMed Central. Accessed May 29 2025.
    9. \n
  9. Ducci, F., & Goldman, D. (2012). The Genetic Basis of Addictive Disorders. Psychiatric Clinics of North America, 35(2), 495–519. PubMed Central. Accessed May 29 2025.
    10. \n
  10. Alhammad, M., Aljedani, R., Alsaleh, M., Atyia, N., Alsmakh, M., Alfaraj, A., Alkhunaizi, A., Alwabari, J., & Alzaidi, M. (2022). Family, Individual, and Other Risk Factors Contributing to Risk of Substance Abuse in Young Adults: A Narrative Review. Cureus, 14(12). PubMed Central. Accessed May 29 2025.
    11. \n
  11. Substance use and co-occurring mental disorders. (2024, March). National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.
    12. \n
  12. American Psychological Association. (2013). Integrated Health Care. American Psychological Association. American Psychological Association. Accessed May 29 2025.
    13. \n
  13. McGovern, M. P., & Carroll, K. M. (2003). Evidence-based practices for substance use disorders. The Psychiatric Clinics of North America, 26(4), 991–1010. PubMed Central. Accessed May 29 2025.
    14. \n
  14. National Institute of Mental Health. (2023). Mental Health Medications. National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.
    15. \n

Medical Content

The Clinical Affairs Team at MentalHealth.com is a dedicated group of medical professionals with diverse and extensive clinical experience. They actively contribute to the development of content, products, and services, and meticulously review all medical material before publication to ensure accuracy and alignment with current research and conversations in mental health. For more information, please visit the Editorial Policy.

About MentalHealth.com

MentalHealth.com helps people understand themselves, build healthier relationships, and access the right care. We bring together mental health education, diagnostics, and care management to support well-being throughout every phase of life.

\"\"

Author

Simone Hoermann, Ph.D.

Ph.D.

Simone Hoermann, Ph.D., is a NYC-based psychologist specializing in personality disorders, anxiety, and depression. With over 15 years in private practice and experience at Columbia University Medical Center, she helps clients navigate stress, relationships, and life transitions through evidence-based therapy.

Published
Updated
\"\"

Medical Reviewer

Carlos Protzel, Psy.D.

Clinical Care Director

Carlos Protzel, Psy.D., LCSW, is a PSYPACT-certified psychologist with 25+ years of experience. He specializes in integrative care using evidence-based and humanistic therapies.

Reviewed

Subject matter expert

\"\"

Roger P. Watts Ph.D.

Addiction therapy and recovery

View experience
\"\"

Related communities

Addiction

Connect around the experiences, relationships, and questions that surround addiction.

Explore community
","text":"HomeLibraryAssessments & DiagnosisDual Diagnosis in Mental Health and AddictionDual Diagnosis in Mental Health and AddictionWritten by Simone Hoermann, Ph.D.Medically reviewed by Carlos Protzel, Psy.D.Published on May 27, 2025 · Updated on May 12, 2026A dual diagnosis occurs when an individual experiences both a mental health condition and a substance use disorder simultaneously. This co-occurrence is more common than many realize, and it presents unique challenges in diagnosis and treatment. Mental health issues such as depression, anxiety, or bipolar disorder can contribute to substance use. At the same time, addiction can worsen or trigger psychiatric symptoms, significantly impacting a person’s physical, emotional, and social well-being. Effective treatment requires an integrated, holistic approach that addresses both conditions at the same time.Key takeawaysDual diagnosis involves a mental health condition occurring alongside a substance use disorder.Overlapping symptoms and reciprocal worsening can make recognition and treatment more complex.Integrated care combines appropriate therapies, medication, and support to address both conditions together.What Is a Dual Diagnosis?Dual diagnosis, also known as co-occurring disorders, refers to the presence of both a mental health condition and a substance use disorder. These conditions often develop together and can significantly impact one another, intensifying symptoms and complicating treatment. For example, an individual struggling with depression may become dependent on benzodiazepines, or someone with post-traumatic stress disorder (PTSD) might develop an opioid use disorder. These conditions often share overlapping biological, psychological, and social risk factors, which may explain why they frequently appear together [1].Understanding these shared influences is essential for developing effective, integrated treatment approaches that address both issues simultaneously [2].One of the most common pathways to co-occurring disorders is self-medication. Individuals experiencing mental health symptoms may turn to substances like alcohol or drugs to numb emotional pain or manage anxiety. However, self-medicating provides only temporary relief and can quickly lead to addiction, creating a destructive cycle where mental illness and substance use continuously reinforce each other [3].Common Co-Occurring Mental Health Disorders and AddictionsMany substance use disorders co-occur with mental health conditions. However, some pairings are seen more frequently than others. These include: Depression and Alcohol​​When exploring the intersection of mental health and addiction, one of the most common and well-documented co-occurring disorders is depression paired with alcohol use disorder. On their own, these are two of the most prevalent psychiatric conditions—but when they occur together, they can significantly worsen one another. Research shows that individuals with alcohol use disorder are more than twice as likely to experience depression [4].Both conditions can run in families, pointing to a genetic predisposition that increases vulnerability to developing one or both. However, genetics is only part of the story. A range of social and environmental factors, such as adverse childhood experiences, trauma, chronic stress, or poor living conditions, can also play a significant role in increasing the risk of both alcohol misuse and depression [5].Understanding this overlap is essential for delivering effective, integrated treatment that addresses dual diagnosis's emotional and behavioral components.Anxiety and Prescription DrugsPeople with anxiety are at an increased risk of developing a prescription drug addiction. Prescription drug abuse can either involve non-medical use (individuals with a prescription but using the drug outside of the intended use or frequency) or use without a prescription. Although both forms of prescription misuse occur at higher rates in individuals with anxiety, non-medical use is more than twice as likely to happen when compared to use without a prescription [6].It is generally believed that self-medicating is a significant motivator for this behavior. People with uncontrolled anxiety often turn to increased amounts of more potent medications in an attempt to dull anxious feelings [6]. Attention-deficit/hyperactivity disorder (ADHD) and Stimulant UseMany people are concerned about the possibility of addiction amongst individuals prescribed stimulants to treat attention-deficit hyperactivity disorder (ADHD). However, extensive research has conclusively disproven this assertion. Studies have shown that prescribing stimulants appropriately to people with ADHD reduces the risk of developing a substance use disorder [7].There may be a slightly increased risk of non-prescription stimulant use in people with ADHD symptoms who have not received a formal diagnosis. However, the evidence is unclear if this causes an increased risk of addiction. This underscores the importance of recognizing dual diagnoses early, as overlapping symptoms can mask underlying conditions and complicate treatment outcomes [7]. Recognizing the Signs of Addiction and Mental Health StrugglesAddiction and mental health conditions can manifest in many different ways. It's not always obvious when someone is struggling; in many cases, the warning signs can be subtle or easily overlooked.Some common signs of a potential substance use disorder include [8]: Using substances in larger amounts or for more extended periods than intended. Wanting to cut down or stop, but feeling unable to. Experiencing negative effects on daily responsibilities, education, work, or relationships. Continuing to use substances despite knowing they cause harm. Developing a tolerance and experiencing withdrawal symptoms when not using. Mental health symptoms can vary widely depending on the condition, but when combined with substance use, these symptoms often become more severe. Co-occurring addiction may worsen emotional distress, impair day-to-day functioning, and further isolate individuals from supportive relationships, making it even harder to seek and receive help.Risk Factors for Addiction and Mental Health ConditionsHealthcare professionals classify addiction as a mental health disorder. This is because although many substances have a physical dependence aspect, addiction is primarily a behavioral and psychological condition. This becomes clear when we look at some of the shared dual diagnosis risk factors for both addiction and other mental health conditions: Genetics: A person’s genes can increase the risk of developing an addiction or a mental health disorder. Specific ‘risk genes’, inherited response to dopamine (the brain’s reward chemical), and genetic personality factors (such as increased neuroticism and impulsivity) affect the risk of developing these co-occurring conditions [9]. Environmental: Environmental factors, such as exposure to substance misuse and parental mental health difficulties, can increase the risk of developing both conditions. Other childhood factors, such as experiencing trauma, abuse, or neglect, can also impact an individual’s experience of these diseases [10]. Social: Wider socio-economic influences can also have a significant impact on a person’s risk of developing addiction or another mental health disorder. Lack of education, resources, and healthcare access all contribute to this risk [10]. The Challenges of a Dual DiagnosisThe overlap in symptoms between addiction and other mental health problems can make an accurate diagnosis tricky. Specialists can use assessment tools to prevent misdiagnosis and arrange the correct treatment for both conditions. Both conditions must be treated together, focusing on each individual’s needs [11].Integrated care is one of the best ways to treat co-occurring conditions effectively. This approach involves collaboration among various healthcare professionals to establish an assessment and treatment plan that addresses the patient’s physical, psychological, and social needs. Studies have shown that integrated care improves symptoms, enhances access to services, improves quality of care, and reduces healthcare costs [12].Without simultaneous treatment, patients risk entering a cycle where untreated mental health symptoms perpetuate substance use, and vice versa, making recovery nearly impossible without addressing both conditions holistically.Therapeutic Approaches for Co-Occurring Mental Health and Addiction DisordersEffective treatment for co-occurring mental health and substance use disorders often requires a comprehensive, integrated approach. Rehabilitation programs that address both conditions simultaneously are considered the cornerstone of intensive care. Several types of therapy have proven effective in treating these comorbid conditions [13]: Self-Help Groups: Programs such as 12-step fellowships (e.g., Alcoholics Anonymous or Narcotics Anonymous) are widely used in addiction recovery. While these groups may not directly address mental health conditions, they foster community, accountability, and shared experience, elements that can reduce isolation and support emotional healing in those with co-occurring psychiatric symptoms. Brief Interventions: For individuals with mild or early-stage addiction, brief interventions conducted by primary care physicians or specialists can be effective. These interventions typically involve screening, brief counseling, and follow-up, and may address underlying mental health issues contributing to substance use. Cognitive Behavioral Therapy (CBT): CBT is one of the most widely used evidence-based therapies for co-occurring disorders. It helps individuals identify harmful thought patterns, understand behavioral triggers, and develop healthy coping strategies. CBT is especially valuable in treating comorbidity because it targets the link between substance use and mental health symptoms, improving the likelihood of sustained recovery. Psychodynamic Psychotherapy: This approach focuses on uncovering the root causes of emotional distress, often tracing back to early life experiences and unresolved trauma. By exploring the underlying psychological drivers of both addiction and mental health conditions, individuals gain deeper insight into their behaviors, which can support long-term healing. Each of these therapies may be used independently or in combination as part of a personalized treatment plan, depending on the individual’s needs and the severity of their conditions.Medication for Mental Health Conditions and AddictionMedication is an essential part of the treatment of many addictions and mental health disorders. Healthcare professionals take great care to ensure that any prescribed medications do not worsen the symptoms of other co-occurring disorders. Several medications may have a beneficial effect in treating more than one condition. The use of medication in treating mental health conditions is most effective when done alongside therapy and other social interventions.Some common groups of medications that doctors prescribe to treat mental health disorders include [13][14]: Antidepressants: Commonly used to treat depression, these medications can help in the treatment of other conditions (such as anxiety or chronic pain). Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed type of antidepressant. Addiction commonly involves an element of low mood that can be treated with antidepressants. Anti-Anxiety Medications: These medications treat anxiety, panic attacks, and extreme phobias. SSRIs and other antidepressants can have an anti-anxiety action. Benzodiazepines are another type of anti-anxiety medication, but these are used with caution in people with a substance use disorder as they can be addictive. Anti-anxiety medications may be used during substance detox or abstinence to counteract the increased anxiety that this process can commonly result in. Mood Stabilizers: These medications are used to treat bipolar disorder, as well as other disorders involving impulse control. Lithium, as well as some anti-epilepsy medications, are commonly used as mood stabilizers. These drugs can have significant side effects, so people who take them must undergo regular monitoring. Treating a co-occurring bipolar or impulse control disorder can reduce the chance of relapse in individuals with a substance use disorder. Medications for Addiction: There are many different medications used to treat addiction, depending on the specific substance involved. Disulfiram and acamprosate are prescribed for alcohol use disorder. Methadone and buprenorphine are commonly used to treat opioid addiction. Other medications, such as naltrexone, can be used as part of the treatment for a variety of substance addictions. These medications all have different effects that can potentially improve or worsen symptoms of a co-occurring disorder. Understanding how medications are used to treat these conditions can be challenging. For more information and advice on what medications may suit you, seek help from your healthcare provider.Managing Co-Occurring DisordersCo-occurring disorders represent a complex and often intertwined relationship between mental health conditions and substance use disorders. These conditions frequently share underlying risk factors, such as trauma, genetic predisposition, and chronic stress, which can make early recognition and targeted intervention especially important. When left untreated, one disorder can worsen the symptoms of the other, creating a cycle that is difficult to break.Integrated, comprehensive care is essential for successful treatment. Approaching both mental health and addiction simultaneously, rather than in isolation, helps individuals build insight, develop healthier coping mechanisms, and reduce the risk of relapse. Treatment often includes therapy, medication, peer support, and lifestyle changes tailored to individual needs.With early intervention, a strong support system, and access to appropriate clinical care, recovery is possible and realistic. Individuals can regain control, improve well-being, and achieve a sustainable, healthier future.References National Institute on Drug Abuse. (2024, April 19). Co-Occurring Disorders and Health Conditions | National Institute on Drug Abuse. National Institute on Drug Abuse. National Institute on Drug Abuse. Accessed May 29 2025. Hardie, M. (2021). Three Aspects of Health and Healing: The Biopsychosocial Model in Medicine. Washington School of Medicine in St. Louis Department of Surgery. surgery.wustl.edu. Accessed May 29 2025. Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. PubMed. Accessed May 29 2025. McHugh, R. K., & Weiss, R. D. (2019). Alcohol Use Disorder and Depressive Disorders. Alcohol Research: Current Reviews, 40(1). PubMed Central. Accessed May 29 2025. Substance use and co-occurring mental disorders. (2024, March). National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025. Fenton, M. C., Keyes, K. M., Martins, S. S., & Hasin, D. S. (2010). The Role of a Prescription in Anxiety Medication Use, Abuse, and Dependence. American Journal of Psychiatry, 167(10), 1247–1253. PubMed Central. Accessed May 29 2025. Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2013). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885. PubMed. Accessed May 29 2025. McLellan, A. T. (2017). Substance Misuse and Substance use Disorders: Why do they Matter in Healthcare? Transactions of the American Clinical and Climatological Association, 128, 112. PubMed Central. Accessed May 29 2025. Ducci, F., & Goldman, D. (2012). The Genetic Basis of Addictive Disorders. Psychiatric Clinics of North America, 35(2), 495–519. PubMed Central. Accessed May 29 2025. Alhammad, M., Aljedani, R., Alsaleh, M., Atyia, N., Alsmakh, M., Alfaraj, A., Alkhunaizi, A., Alwabari, J., & Alzaidi, M. (2022). Family, Individual, and Other Risk Factors Contributing to Risk of Substance Abuse in Young Adults: A Narrative Review. Cureus, 14(12). PubMed Central. Accessed May 29 2025. Substance use and co-occurring mental disorders. (2024, March). National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025. American Psychological Association. (2013). Integrated Health Care. American Psychological Association. American Psychological Association. Accessed May 29 2025. McGovern, M. P., & Carroll, K. M. (2003). Evidence-based practices for substance use disorders. The Psychiatric Clinics of North America, 26(4), 991–1010. PubMed Central. Accessed May 29 2025. National Institute of Mental Health. (2023). Mental Health Medications. National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025. Medical ContentThe Clinical Affairs Team at MentalHealth.com is a dedicated group of medical professionals with diverse and extensive clinical experience. They actively contribute to the development of content, products, and services, and meticulously review all medical material before publication to ensure accuracy and alignment with current research and conversations in mental health. For more information, please visit the Editorial Policy.About MentalHealth.comMentalHealth.com helps people understand themselves, build healthier relationships, and access the right care. We bring together mental health education, diagnostics, and care management to support well-being throughout every phase of life.AuthorSimone Hoermann, Ph.D.Ph.D.Simone Hoermann, Ph.D., is a NYC-based psychologist specializing in personality disorders, anxiety, and depression. With over 15 years in private practice and experience at Columbia University Medical Center, she helps clients navigate stress, relationships, and life transitions through evidence-based therapy.PublishedMay 27, 2025UpdatedMay 12, 2026Medical ReviewerCarlos Protzel, Psy.D.Clinical Care DirectorCarlos Protzel, Psy.D., LCSW, is a PSYPACT-certified psychologist with 25+ years of experience. He specializes in integrative care using evidence-based and humanistic therapies.ReviewedMay 27, 2025Subject matter expertRoger P. Watts Ph.D.Addiction therapy and recoveryView experienceRelated communitiesAddictionConnect around the experiences, relationships, and questions that surround addiction.Explore communityTable of contentsChoose a sectionWhat Is a Dual Diagnosis?Common Co-Occurring Mental Health Disorders and AddictionsSigns of addiction and mental health strugglesThe Challenges of a Dual DiagnosisTreating co-occurring mental health and addiction issuesMedication for Mental Health Conditions and AddictionManaging Co-Occurring DisordersView moreSubject matter expertRoger P. Watts Ph.D.Addiction therapy and recoveryView experienceRelated communitiesAddictionConnect around the experiences, relationships, and questions that surround addiction.Explore community","wordCount":2604},"schema":{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/#organization","name":"MentalHealth.com","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/"},{"@type":"WebSite","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/#website","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/","name":"MentalHealth.com","inLanguage":"en-US","publisher":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/#organization"}},{"@type":"BreadcrumbList","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://mentalhealth-v2.workspace-454808.chatgpt.site/"},{"@type":"ListItem","position":2,"name":"Library","item":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library"},{"@type":"ListItem","position":3,"name":"Assessments & Diagnosis","item":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/assessments-diagnosis"},{"@type":"ListItem","position":4,"name":"Dual Diagnosis in Mental Health and Addiction","item":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis"}]},{"@type":"ImageObject","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#primaryimage","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/library/editorial-12785.webp","contentUrl":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/library/editorial-12785.webp","width":1200,"height":800,"encodingFormat":"image/webp","caption":"A group of adults talks together in a comfortable counseling room."},{"@type":"Person","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/simone-hoermann#person","name":"Simone Hoermann, Ph.D.","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/simone-hoermann","jobTitle":"Ph.D.","image":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/wordpress/9447.jpg"},{"@type":"Person","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/carlos-protzel#person","name":"Carlos Protzel, Psy.D.","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/carlos-protzel","jobTitle":"Clinical Care Director","image":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/wordpress/13152.jpeg","sameAs":["https://www.linkedin.com/in/carlos-protzel-lcsw-psyd-aa73aa12/"]},{"@type":"Article","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#article","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis","headline":"Dual Diagnosis in Mental Health and Addiction","description":"Discover how dual diagnoses combine mental health and addiction disorders, sharing risk factors and complicating treatment.","wordCount":1954,"mainEntityOfPage":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#webpage"},"publisher":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/#organization"},"articleSection":"Library","citation":[{"@type":"CreativeWork","name":"National Institute on Drug Abuse. (2024, April 19). Co-Occurring Disorders and Health Conditions | National Institute on Drug Abuse. National Institute on Drug Abuse. National Institute on Drug Abuse. Accessed May 29 2025.","url":"https://nida.nih.gov/research-topics/co-occurring-disorders-health-conditions"},{"@type":"CreativeWork","name":"Hardie, M. (2021). Three Aspects of Health and Healing: The Biopsychosocial Model in Medicine. Washington School of Medicine in St. Louis Department of Surgery. surgery.wustl.edu. Accessed May 29 2025.","url":"https://surgery.wustl.edu/three-aspects-of-health-and-healing-the-biopsychosocial-model/"},{"@type":"CreativeWork","name":"Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. PubMed. Accessed May 29 2025.","url":"https://pubmed.ncbi.nlm.nih.gov/9385000/"},{"@type":"CreativeWork","name":"McHugh, R. K., & Weiss, R. D. (2019). Alcohol Use Disorder and Depressive Disorders. Alcohol Research: Current Reviews, 40(1). PubMed Central. Accessed May 29 2025.","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6799954/"},{"@type":"CreativeWork","name":"Substance use and co-occurring mental disorders. (2024, March). National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.","url":"https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health"},{"@type":"CreativeWork","name":"Fenton, M. C., Keyes, K. M., Martins, S. S., & Hasin, D. S. (2010). The Role of a Prescription in Anxiety Medication Use, Abuse, and Dependence. American Journal of Psychiatry, 167(10), 1247–1253. PubMed Central. Accessed May 29 2025.","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3756550/"},{"@type":"CreativeWork","name":"Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2013). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885. PubMed. Accessed May 29 2025.","url":"https://pubmed.ncbi.nlm.nih.gov/25158998/"},{"@type":"CreativeWork","name":"McLellan, A. T. (2017). Substance Misuse and Substance use Disorders: Why do they Matter in Healthcare? Transactions of the American Clinical and Climatological Association, 128, 112. PubMed Central. Accessed May 29 2025.","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5525418/"},{"@type":"CreativeWork","name":"Ducci, F., & Goldman, D. (2012). The Genetic Basis of Addictive Disorders. Psychiatric Clinics of North America, 35(2), 495–519. PubMed Central. Accessed May 29 2025.","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3506170/"},{"@type":"CreativeWork","name":"Alhammad, M., Aljedani, R., Alsaleh, M., Atyia, N., Alsmakh, M., Alfaraj, A., Alkhunaizi, A., Alwabari, J., & Alzaidi, M. (2022). Family, Individual, and Other Risk Factors Contributing to Risk of Substance Abuse in Young Adults: A Narrative Review. Cureus, 14(12). PubMed Central. Accessed May 29 2025.","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9731175/"},{"@type":"CreativeWork","name":"Substance use and co-occurring mental disorders. (2024, March). National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.","url":"https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health"},{"@type":"CreativeWork","name":"American Psychological Association. (2013). Integrated Health Care. American Psychological Association. American Psychological Association. Accessed May 29 2025.","url":"https://www.apa.org/health/integrated-health-care"},{"@type":"CreativeWork","name":"McGovern, M. P., & Carroll, K. M. (2003). Evidence-based practices for substance use disorders. The Psychiatric Clinics of North America, 26(4), 991–1010. PubMed Central. Accessed May 29 2025.","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3678283/"},{"@type":"CreativeWork","name":"National Institute of Mental Health. (2023). Mental Health Medications. National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.","url":"https://www.nimh.nih.gov/health/topics/mental-health-medications"}],"inLanguage":"en-US","datePublished":"2025-05-27T09:14:27Z","dateModified":"2026-05-12T11:52:34Z","author":[{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/simone-hoermann#person"}],"image":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#primaryimage"}},{"@type":"MedicalWebPage","@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#webpage","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis","name":"Dual Diagnosis in Mental Health and Addiction","description":"Discover how dual diagnoses combine mental health and addiction disorders, sharing risk factors and complicating treatment.","inLanguage":"en-US","isPartOf":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/#website"},"breadcrumb":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#breadcrumb"},"mainEntity":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#article"},"relatedLink":["https://mentalhealth-v2.workspace-454808.chatgpt.site/library/addiction","https://mentalhealth-v2.workspace-454808.chatgpt.site/library/diagnosis-vs-self-diagnosis","https://mentalhealth-v2.workspace-454808.chatgpt.site/library/diagnostic-criteria-for-substance-use-disorders","https://mentalhealth-v2.workspace-454808.chatgpt.site/library/risks-of-self-diagnosis","https://mentalhealth-v2.workspace-454808.chatgpt.site/library/behavioral-health","https://mentalhealth-v2.workspace-454808.chatgpt.site/people/roger-watts"],"publisher":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/#organization"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"General public"},"datePublished":"2025-05-27T09:14:27Z","dateModified":"2026-05-12T11:52:34Z","lastReviewed":"2025-05-27","primaryImageOfPage":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#primaryimage"},"image":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#primaryimage"},"reviewedBy":{"@id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/carlos-protzel#person"}}]},"representations":{"html":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis","json":"https://mentalhealth-v2.workspace-454808.chatgpt.site/data/library/mental-health-behavioral-addiction-dual-diagnosis.json","jsonLd":"https://mentalhealth-v2.workspace-454808.chatgpt.site/data/library/mental-health-behavioral-addiction-dual-diagnosis.ld.json"},"$schema":"https://mentalhealth-v2.workspace-454808.chatgpt.site/data/page.schema.json","images":[{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/wordpress/9447.jpg","alt":"","width":22,"height":22},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/wordpress/13152.jpeg","alt":"","width":22,"height":22},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/library/editorial-12785.webp","alt":"A group of adults talks together in a comfortable counseling room.","width":1200,"height":800},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/wordpress/18538.jpeg","alt":"","width":64,"height":64},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/library/editorial-14636.webp","alt":"","width":48,"height":48}],"sections":[{"id":"key-takeaways","title":"Key takeaways","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#key-takeaways"},{"id":"what-is-a-dual-diagnosis","title":"What Is a Dual Diagnosis?","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#what-is-a-dual-diagnosis"},{"id":"common-co-occurring-mental-health-disorders-and-addictions","title":"Common Co-Occurring Mental Health Disorders and Addictions","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#common-co-occurring-mental-health-disorders-and-addictions"},{"id":"depression-and-alcohol","title":"Depression and Alcohol","level":3,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#depression-and-alcohol"},{"id":"anxiety-and-prescription-drugs","title":"Anxiety and Prescription Drugs","level":3,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#anxiety-and-prescription-drugs"},{"id":"adhd-and-stimulant-use","title":"Attention-deficit/hyperactivity disorder (ADHD) and Stimulant Use","level":3,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#adhd-and-stimulant-use"},{"id":"signs-of-addiction-and-mental-health-struggles","title":"Recognizing the Signs of Addiction and Mental Health Struggles","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#signs-of-addiction-and-mental-health-struggles"},{"id":"risk-factors-for-addiction-and-mental-health-conditions","title":"Risk Factors for Addiction and Mental Health Conditions","level":3,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#risk-factors-for-addiction-and-mental-health-conditions"},{"id":"the-challenges-of-a-dual-diagnosis","title":"The Challenges of a Dual Diagnosis","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#the-challenges-of-a-dual-diagnosis"},{"id":"treating-co-occurring-mental-health-and-addiction-issues","title":"Therapeutic Approaches for Co-Occurring Mental Health and Addiction Disorders","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#treating-co-occurring-mental-health-and-addiction-issues"},{"id":"medication-for-mental-health-conditions-and-addiction","title":"Medication for Mental Health Conditions and Addiction","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#medication-for-mental-health-conditions-and-addiction"},{"id":"managing-co-occurring-disorders","title":"Managing Co-Occurring Disorders","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#managing-co-occurring-disorders"},{"id":"references-2","title":"References","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#references-2"},{"id":"medical-content","title":"Medical Content","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#medical-content"},{"id":"about-mentalhealth-com","title":"About MentalHealth.com","level":2,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#about-mentalhealth-com"},{"id":"simone-hoermann-ph-d","title":"Simone Hoermann, Ph.D.","level":3,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#simone-hoermann-ph-d"},{"id":"carlos-protzel-psy-d","title":"Carlos Protzel, Psy.D.","level":3,"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#carlos-protzel-psy-d"}],"references":[{"number":1,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#co-occurring-disorders-health-conditions-national-institute-drug-abuse","text":"National Institute on Drug Abuse. (2024, April 19). Co-Occurring Disorders and Health Conditions | National Institute on Drug Abuse. National Institute on Drug Abuse. National Institute on Drug Abuse. Accessed May 29 2025.","links":[{"url":"https://nida.nih.gov/research-topics/co-occurring-disorders-health-conditions","label":"National Institute on Drug Abuse"}],"url":"https://nida.nih.gov/research-topics/co-occurring-disorders-health-conditions"},{"number":2,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#three-aspects-health-healing-biopsychosocial-model-medicine","text":"Hardie, M. (2021). Three Aspects of Health and Healing: The Biopsychosocial Model in Medicine. Washington School of Medicine in St. Louis Department of Surgery. surgery.wustl.edu. Accessed May 29 2025.","links":[{"url":"https://surgery.wustl.edu/three-aspects-of-health-and-healing-the-biopsychosocial-model/","label":"surgery.wustl.edu"}],"url":"https://surgery.wustl.edu/three-aspects-of-health-and-healing-the-biopsychosocial-model/"},{"number":3,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#self-medication-hypothesis-substance-use-disorders-reconsideration-recent-applications","text":"Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. PubMed. Accessed May 29 2025.","links":[{"url":"https://pubmed.ncbi.nlm.nih.gov/9385000/","label":"PubMed"}],"url":"https://pubmed.ncbi.nlm.nih.gov/9385000/"},{"number":4,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#alcohol-use-disorder-depressive-disorders","text":"McHugh, R. K., & Weiss, R. D. (2019). Alcohol Use Disorder and Depressive Disorders. Alcohol Research: Current Reviews, 40(1). PubMed Central. Accessed May 29 2025.","links":[{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6799954/","label":"PubMed Central"}],"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6799954/"},{"number":5,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#national-institute-mental-health","text":"Substance use and co-occurring mental disorders. (2024, March). National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.","links":[{"url":"https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health","label":"National Institute of Mental Health"}],"url":"https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health"},{"number":6,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#role-prescription-anxiety-medication-use-abuse-dependence","text":"Fenton, M. C., Keyes, K. M., Martins, S. S., & Hasin, D. S. (2010). The Role of a Prescription in Anxiety Medication Use, Abuse, and Dependence. American Journal of Psychiatry, 167(10), 1247–1253. PubMed Central. Accessed May 29 2025.","links":[{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3756550/","label":"PubMed Central"}],"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3756550/"},{"number":7,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#stimulant-adhd-medication-risk-substance-abuse","text":"Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2013). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885. PubMed. Accessed May 29 2025.","links":[{"url":"https://pubmed.ncbi.nlm.nih.gov/25158998/","label":"PubMed"}],"url":"https://pubmed.ncbi.nlm.nih.gov/25158998/"},{"number":8,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#substance-misuse-substance-use-disorders-why-do-they-matter","text":"McLellan, A. T. (2017). Substance Misuse and Substance use Disorders: Why do they Matter in Healthcare? Transactions of the American Clinical and Climatological Association, 128, 112. PubMed Central. Accessed May 29 2025.","links":[{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5525418/","label":"PubMed Central"}],"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5525418/"},{"number":9,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#genetic-basis-addictive-disorders","text":"Ducci, F., & Goldman, D. (2012). The Genetic Basis of Addictive Disorders. Psychiatric Clinics of North America, 35(2), 495–519. PubMed Central. Accessed May 29 2025.","links":[{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3506170/","label":"PubMed Central"}],"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3506170/"},{"number":10,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#family-individual-other-risk-factors-contributing-risk-substance-abuse","text":"Alhammad, M., Aljedani, R., Alsaleh, M., Atyia, N., Alsmakh, M., Alfaraj, A., Alkhunaizi, A., Alwabari, J., & Alzaidi, M. (2022). Family, Individual, and Other Risk Factors Contributing to Risk of Substance Abuse in Young Adults: A Narrative Review. Cureus, 14(12). PubMed Central. Accessed May 29 2025.","links":[{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9731175/","label":"PubMed Central"}],"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9731175/"},{"number":11,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#national-institute-mental-health-source","text":"Substance use and co-occurring mental disorders. (2024, March). National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.","links":[{"url":"https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health","label":"National Institute of Mental Health"}],"url":"https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health"},{"number":12,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#integrated-health-care","text":"American Psychological Association. (2013). Integrated Health Care. American Psychological Association. American Psychological Association. Accessed May 29 2025.","links":[{"url":"https://www.apa.org/health/integrated-health-care","label":"American Psychological Association"}],"url":"https://www.apa.org/health/integrated-health-care"},{"number":13,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#evidence-based-practices-substance-use-disorders","text":"McGovern, M. P., & Carroll, K. M. (2003). Evidence-based practices for substance use disorders. The Psychiatric Clinics of North America, 26(4), 991–1010. PubMed Central. Accessed May 29 2025.","links":[{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3678283/","label":"PubMed Central"}],"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3678283/"},{"number":14,"id":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#mental-health-medications","text":"National Institute of Mental Health. (2023). Mental Health Medications. National Institute of Mental Health. National Institute of Mental Health. Accessed May 29 2025.","links":[{"url":"https://www.nimh.nih.gov/health/topics/mental-health-medications","label":"National Institute of Mental Health"}],"url":"https://www.nimh.nih.gov/health/topics/mental-health-medications"}],"relatedReading":[],"links":[{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/","label":"Home"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library","label":"Library"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/assessments-diagnosis","label":"Assessments & Diagnosis"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/simone-hoermann","label":"Simone Hoermann, Ph.D."},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/carlos-protzel","label":"Carlos Protzel, Psy.D."},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/social-cultural-topics","label":"social risk factors"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#co-occurring-disorders-health-conditions-national-institute-drug-abuse","label":"[1]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#three-aspects-health-healing-biopsychosocial-model-medicine","label":"[2]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#self-medication-hypothesis-substance-use-disorders-reconsideration-recent-applications","label":"[3]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/alcohol-use-disorder","label":"individuals with alcohol use disorder are more than twice as likely to experience depression"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#alcohol-use-disorder-depressive-disorders","label":"[4]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#national-institute-mental-health","label":"[5]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#role-prescription-anxiety-medication-use-abuse-dependence","label":"[6]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#role-prescription-anxiety-medication-use-abuse-dependence","label":"[6]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#stimulant-adhd-medication-risk-substance-abuse","label":"[7]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#stimulant-adhd-medication-risk-substance-abuse","label":"[7]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#substance-misuse-substance-use-disorders-why-do-they-matter","label":"[8]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/psychological-causes-of-addiction","label":"addiction is primarily a behavioral and psychological condition"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#genetic-basis-addictive-disorders","label":"[9]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#family-individual-other-risk-factors-contributing-risk-substance-abuse","label":"[10]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#family-individual-other-risk-factors-contributing-risk-substance-abuse","label":"[10]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#national-institute-mental-health-source","label":"[11]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#integrated-health-care","label":"[12]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#evidence-based-practices-substance-use-disorders","label":"[13]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#evidence-based-practices-substance-use-disorders","label":"[13]"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#mental-health-medications","label":"[14]"},{"url":"https://nida.nih.gov/research-topics/co-occurring-disorders-health-conditions","label":"National Institute on Drug Abuse"},{"url":"https://surgery.wustl.edu/three-aspects-of-health-and-healing-the-biopsychosocial-model/","label":"surgery.wustl.edu"},{"url":"https://pubmed.ncbi.nlm.nih.gov/9385000/","label":"PubMed"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6799954/","label":"PubMed Central"},{"url":"https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health","label":"National Institute of Mental Health"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3756550/","label":"PubMed Central"},{"url":"https://pubmed.ncbi.nlm.nih.gov/25158998/","label":"PubMed"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5525418/","label":"PubMed Central"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3506170/","label":"PubMed Central"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9731175/","label":"PubMed Central"},{"url":"https://www.nimh.nih.gov/health/topics/substance-use-and-mental-health","label":"National Institute of Mental Health"},{"url":"https://www.apa.org/health/integrated-health-care","label":"American Psychological Association"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3678283/","label":"PubMed Central"},{"url":"https://www.nimh.nih.gov/health/topics/mental-health-medications","label":"National Institute of Mental Health"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/clinical-affairs","label":"The Clinical Affairs Team"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/publishing/editorial-policy","label":"Editorial Policy"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/simone-hoermann","label":"Simone Hoermann, Ph.D."},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/carlos-protzel","label":"Carlos Protzel, Psy.D."},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/roger-watts","label":"Roger P. Watts Ph.D."},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/roger-watts","label":"View experience"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/community/addiction","label":"Explore community"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#what-is-a-dual-diagnosis","label":"What Is a Dual Diagnosis?"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#common-co-occurring-mental-health-disorders-and-addictions","label":"Common Co-Occurring Mental Health Disorders and Addictions"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#signs-of-addiction-and-mental-health-struggles","label":"Signs of addiction and mental health struggles"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#the-challenges-of-a-dual-diagnosis","label":"The Challenges of a Dual Diagnosis"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#treating-co-occurring-mental-health-and-addiction-issues","label":"Treating co-occurring mental health and addiction issues"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#medication-for-mental-health-conditions-and-addiction","label":"Medication for Mental Health Conditions and Addiction"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis#managing-co-occurring-disorders","label":"Managing Co-Occurring Disorders"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/roger-watts","label":"Roger P. Watts Ph.D."},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/people/roger-watts","label":"View experience"},{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/community/addiction","label":"Explore community"}],"seo":{"title":"Dual Diagnosis in Mental Health and Addiction | MentalHealth.com","description":"Discover how dual diagnoses combine mental health and addiction disorders, sharing risk factors and complicating treatment.","canonical":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis","robots":"index,follow","socialImage":{"url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/assets/social-tiles-20261006-dots/library.png","width":1200,"height":630,"alt":"MentalHealth.com — Library","type":"image/png","sitemapGroup":"library"}},"breadcrumbs":[{"name":"Home","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/"},{"name":"Library","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library"},{"name":"Assessments & Diagnosis","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/assessments-diagnosis"},{"name":"Dual Diagnosis in Mental Health and Addiction","url":"https://mentalhealth-v2.workspace-454808.chatgpt.site/library/mental-health-behavioral-addiction-dual-diagnosis"}],"subjectMatterExpert":{"name":"Roger P. Watts, Ph.D.","url":"/people/roger-watts","profileId":"6374","topic":"addiction","focus":"Addiction therapy and recovery","selectionBasis":"Documented expertise in the existing published profile","reviewAttribution":false},"keyTakeaways":["Dual diagnosis involves a mental health condition occurring alongside a substance use disorder.","Overlapping symptoms and reciprocal worsening can make recognition and treatment more complex.","Integrated care combines appropriate therapies, medication, and support to address both conditions together."],"introduction":{"html":"A dual diagnosis occurs when an individual experiences both a mental health condition and a substance use disorder simultaneously. This co-occurrence is more common than many realize, and it presents unique challenges in diagnosis and treatment. Mental health issues such as depression, anxiety, or bipolar disorder can contribute to substance use. At the same time, addiction can worsen or trigger psychiatric symptoms, significantly impacting a person’s physical, emotional, and social well-being. Effective treatment requires an integrated, holistic approach that addresses both conditions at the same time.","text":"A dual diagnosis occurs when an individual experiences both a mental health condition and a substance use disorder simultaneously. This co-occurrence is more common than many realize, and it presents unique challenges in diagnosis and treatment. Mental health issues such as depression, anxiety, or bipolar disorder can contribute to substance use. At the same time, addiction can worsen or trigger psychiatric symptoms, significantly impacting a person’s physical, emotional, and social well-being. Effective treatment requires an integrated, holistic approach that addresses both conditions at the same time.","sourceField":"hero"},"navigation":[{"label":"What Is a Dual Diagnosis?","href":"#what-is-a-dual-diagnosis","heading":"What Is a Dual Diagnosis?"},{"label":"Common Co-Occurring Mental Health Disorders and Addictions","href":"#common-co-occurring-mental-health-disorders-and-addictions","heading":"Common Co-Occurring Mental Health Disorders and Addictions"},{"label":"Signs of addiction and mental health struggles","href":"#signs-of-addiction-and-mental-health-struggles","heading":"Recognizing the Signs of Addiction and Mental Health Struggles"},{"label":"The Challenges of a Dual Diagnosis","href":"#the-challenges-of-a-dual-diagnosis","heading":"The Challenges of a Dual Diagnosis"},{"label":"Treating co-occurring mental health and addiction issues","href":"#treating-co-occurring-mental-health-and-addiction-issues","heading":"Therapeutic Approaches for Co-Occurring Mental Health and Addiction Disorders"},{"label":"Medication for Mental Health Conditions and Addiction","href":"#medication-for-mental-health-conditions-and-addiction","heading":"Medication for Mental Health Conditions and Addiction"},{"label":"Managing Co-Occurring Disorders","href":"#managing-co-occurring-disorders","heading":"Managing Co-Occurring Disorders"}],"relatedCommunity":{"community":"/community/addiction","basis":"topic match"},"referencePresentation":"Numbered author–date bibliography with linked source documents; n.d. denotes unavailable publication date.","collections":[]}